Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04980612 · ClinicalTrials.gov registry record · NA
Development and Feasibility of Mindfulness Based Pain Reduction
A NA study of Chronic Low Back Pain, sponsored by University of California, San Francisco.
- Active
- Registry status
- NA
- Development phase
- 52
- Enrollment target
- 1
- Study location
NCT04980612: Active NA study of Chronic Low Back Pain, sponsored by University of California, San Francisco.
NCT04980612 is a NA study of Chronic Low Back Pain that is active but no longer recruiting, run by University of California, San Francisco. The registered enrollment target is 52 participants, below the 591-participant average among 71 other Chronic Low Back Pain trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04980612, a NA study of Chronic Low Back Pain, is active but no longer recruiting, sponsored by University of California, San Francisco.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 52 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a development study with clinical outcomes. The investigators aim to develop and test an 8-week MBPR (Mindfulness-Based Pain Reduction) program, which draws on intervention work and clinical experience in the investigative team to optimize a mindfulness-based intervention for individuals with chronic pain. The overall goal of this study is to ensure that the MBPR program has been carefully refined and manualized in an in-person setting before performing clinical trials comparing MBPR to MBSR (Mindfulness-Based Stress Reduction) to test whether it improves pain outcomes. This study includes a Pain Attention Task that separates insula activation during experimental heat application between different pain attention conditions.
Primary Outcome
Change in average pain intensity in past week on Numeric Rating Scale \[0 to 10\] will be assessed by internet-based questionnaire using REDCap negative values indicate improvement.
Conditions Studied
Interventions
- BEHAVIORAL Mindfulness Based Pain Reduction
- BEHAVIORAL Mindfulness Based Stress Reduction
Study Locations (1)
California
- University of California San Francisco; Osher Center for Intgerative Medicine - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2021-12-14 |
| Est. Completion | 2025-12-01 |
| Phase | NA |
What the registry record for NCT04980612 still lists
NCT04980612 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 52 participants, a relatively small participant target, below the 591-participant average among 71 other Chronic Low Back Pain trials with a reported enrollment target (91% lower).
The record links to 1 condition, with Chronic Low Back Pain appearing as the primary indexed condition, and to 2 interventions - of which Mindfulness Based Pain Reduction is the first listed.
NCT04980612 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04980612 about?
NCT04980612 is a clinical study titled "Development and Feasibility of Mindfulness Based Pain Reduction". This is a development study with clinical outcomes. The investigators aim to develop and test an 8-week MBPR (Mindfulness-Based Pain Reduction) program, which draws on intervention work and clinical experience in the investigative team to optimize a mindfulness-based intervention for individuals wit...
What is the current status of trial NCT04980612?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 52 participants. The study started on 2021-12-14. Estimated completion is 2025-12-01.
What conditions does trial NCT04980612 study?
This clinical trial studies the following conditions: Chronic Low Back Pain.
What interventions are being tested in trial NCT04980612?
The interventions under investigation include: Mindfulness Based Pain Reduction (BEHAVIORAL), Mindfulness Based Stress Reduction (BEHAVIORAL).
Who is sponsoring clinical trial NCT04980612?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04980612 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Low Back Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04980612's enrollment target sits among peer trials
52 43rd of 71 higher than 29 of 71 other Chronic Low Back Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Low Back Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mobile Neurofeedback for Low Back Pain
RECRUITING · NA
-
Phenotyping Response to Spinal Cord Stimulation in Chronic Low Back Pain
RECRUITING · NA
-
Active Music-Based Intervention in Patients With Chronic Low Back Pain
RECRUITING · NA
-
Sequential and Comparative Evaluation of Pain Treatment Effectiveness Response
RECRUITING · NA
-
Meditation for Older Adults With Chronic Low Back Pain
RECRUITING · NA
-
MBM andtaVNS for Low Back Pain and Depressive Symptoms
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02630121 · 52 participants · Phase 4
Effect of Oxymetazoline Hydrochloride in Combination With Fluticasone Propionate on the Apnea Hypopnea Index (AHI) in Subject With Persistent Nasal Congestion and Mild Obstructive Sleep Apnea
- NCT03629171 · 52 participants · Phase 2
Liposome-encapsulated Daunorubicin-Cytarabine and Venetoclax in Treating Participants With Relapsed, Refractory or Untreated Acute Myeloid Leukemia
- NCT04128748 · 52 participants · Phase 1
Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome
- NCT04150497 · 52 participants · Phase 1
Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI